One study reported that ROS levels in BRCA1 and basal-like breast cancer correlated with AhR expression and this increased expression of amphiregulin (AREG), a ligand for the epidermal growth factor receptor (EGFR) [154]. The gene discussed is EGFR; the disease is breast carcinoma.